Rongfu Wang

Title(s)Professor of Pediatrics and Medicine
SchoolKeck School of Medicine of Usc
Address4650 Sunset Blvd, Mail Stop 57
Off Campus
Los Angeles CA 90027
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    CHLA, USC2019Endowed Chair in Cell Therapy Research
    Houston Methodist/Weill Cornell Medicine2016President’s Award for Transformative Excellence
    Houston Methodist/Weill Cornell Medicine2016Award for Excellence in Transformative Research
    Houston Methodist/Weill Cornell Medicine2016Award for Excellence in Research and Publication
    Houston Methodist/Weill Cornell Medicine2013President’s Award for Transformative Excellence
    Baylor College of Medicine2007Jack L. Titus Endowed Professorship
    Baylor College of Medicine2006DeBakey Excellence in Research Award
    American Cancer Society2003American Cancer Society Research Scholar
    National Cancer Institute, NIH1999Intramural Research Award
    NIH1996Recipient of NIH Fellows Award for Research Excellence
    University of Georgia1992Winner of the campus-wide Distinguished Dissertation competition

    Collapse Overview 
    Collapse Overview
    Dr. Rongfu Wang is a Professor of Pediatrics for the Cancer and Blood Disease Institute and the Division of Hematology, Oncology and Transplantation & Cellular Therapy at Children’s Hospital Los Angeles (CHLA), is an Endowed Chair and Director of the Cell Therapy Research Program at CHLA. He is also a Professor of Medicine, the Keck School of Medicine at the University of Southern California.

    Dr. Wang received his Ph.D. degree in Molecular Genetics at the University of Georgia in 1992, and completed his postdoctoral training with the Department of Microbiology and Immunology at Stanford University School of Medicine in 1994. He then completed a Cancer Immunotherapy Fellowship with Dr. Steve Rosenberg at the National Cancer Institute in 1996 and continued as a Senior Investigator until 2000 at the National Cancer Institute, NIH. During his tenure at NCI, Dr. Wang made seminal contributions to cancer antigen discovery and cancer immunotherapy.

    In 2000, Dr. Wang was appointed as an Associate Professor in the Department of Immunology at Baylor College of Medicine. At Baylor, he continued his work in identifying new cancer antigens and developing cancer vaccines. In 2004, Dr. Wang was promoted to Professor with tenure. In 2006, he received the Michael DeBakey Excellence in Research Award and in 2007 he was granted the endowed Jack L. Titus Professorship. In 2011, Dr. Wang moved his laboratory to Houston Methodist Research Institute, where he built and became Director of a new Center for Inflammation and Epigenetics with an appointment as Professor in the Department of Microbiology and Immunology at Weill Cornell Medicine, Cornell University. Because of his outstanding contribution, Dr. Wang received several awards, including Presidential Awards in 2013 and 2016 in Houston Methodist Research Institute. Since 2019, Dr. Wang and his team joined University of Southern California.

    Research interests of Dr. Wang include cancer antigen discovery, cancer immunotherapy, innate immune signaling, and epigenetic reprogramming of stem cells and immune cells. Throughout his career, Dr. Wang has discovered numerous cancer antigens, some (NY-ESO-1) of which have been demonstrated in clinical studies with TCR-T cell immunotherapy. His team has identified antigen-specific regulatory T cells, which can be reversed by Toll-Like Receptor 8 signaling, and discovered critical epigenetic regulators in T-cell differentiation and in induced pluripotent stem cell reprogramming. Dr. Wang’s research findings have been published in the top journals, including Science, Cell, Immunity, Nature Immunology, Nature Medicine, Nature Biotechnology, Cell Metabolism, Cell host & Microbe, JEM, JCI and Mol. Cell. More recently, his team developed novel self-assembled peptide nanoparticles (SAPNANO) technology, novel CAR-T technology and neoantigen discovery platform for vaccine and CAR/TCR-T immunotherapy. To further understand and improve the T cell trafficking and persistence, Dr. Wang and his team reprogram immune cells and tumor microenvironment by using epigenetic, metabolic and microbiota approaches, thus leading to the development of novel and robust cancer therapeutics. In addition, Dr. Wang investigates microbiota and innate immune signaling to modulate immunity against cancer, infectious disease and Alzheimer’s disease.

    Collapse Research 
    Collapse Research Activities and Funding
    CD4+ T cells and neoantigens in melanoma immunotherapy.
    NIH R01CA246547Dec 1, 2020 - Nov 30, 2025
    Role: Principal Investigator
    Development of Novel Vaccines for Cocaine Abuse
    NIH R01DA030338Sep 30, 2010 - Jul 31, 2017
    Role: Principal Investigator
    Antigen specificity, suppressive mechanism ®ulation of CD4+ regulatory T cell
    NIH R01CA116408Aug 11, 2006 - Jul 31, 2013
    Role: Principal Investigator
    Reversal of regulatory T cell function in prostate cancer
    NIH R01CA121191Aug 7, 2006 - Jul 31, 2013
    Role: Principal Investigator
    Novel Strategies for Intervention of Inflammatory Diseases and Cancer
    NIH R01CA101795Jul 1, 2003 - Jun 30, 2023
    Role: Principal Investigator
    The Role of CD4+ T Cells in Antitumor Immunity
    NIH R01CA090327Apr 1, 2001 - Nov 30, 2015
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. BECN2 (beclin 2) Negatively Regulates Inflammasome Sensors Through ATG9A-Dependent but ATG16L1- and LC3-Independent Non-Canonical Autophagy. Autophagy. 2022 02; 18(2):340-356. Deng G, Li C, Chen L, Xing C, Fu C, Qian C, Liu X, Wang HY, Zhu M, Wang RF. PMID: 34152938; PMCID: PMC8942444.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    2. Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host Microbe. 2021 06 09; 29(6):959-974.e7. Xing C, Wang M, Ajibade AA, Tan P, Fu C, Chen L, Zhu M, Hao ZZ, Chu J, Yu X, Yin B, Zhu J, Shen WJ, Duan T, Wang HY, Wang RF. PMID: 33894128; PMCID: PMC8192480.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    3. BECN2 (beclin 2)-mediated non-canonical autophagy in innate immune signaling and tumor development. Autophagy. 2020 12; 16(12):2310-2312. Zhu M, Deng G, Xing C, Nie G, Wang RF. PMID: 33121356; PMCID: PMC7751501.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    4. PHF20 Promotes Glioblastoma Cell Malignancies Through a WISP1/BGN-Dependent Pathway. Front Oncol. 2020; 10:573318. Ma Q, Long W, Xing C, Jiang C, Su J, Wang HY, Liu Q, Wang RF. PMID: 33117706; PMCID: PMC7574681.
      View in: PubMed   Mentions: 4  
    5. Beclin 2 negatively regulates innate immune signaling and tumor development. J Clin Invest. 2020 10 01; 130(10):5349-5369. Zhu M, Deng G, Tan P, Xing C, Guan C, Jiang C, Zhang Y, Ning B, Li C, Yin B, Chen K, Zhao Y, Wang HY, Levine B, Nie G, Wang RF. PMID: 32865519; PMCID: PMC7524487.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    6. RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology. Proc Natl Acad Sci U S A. 2020 08 11; 117(32):19465-19474. He X, Ashbrook AW, Du Y, Wu J, Hoffmann HH, Zhang C, Xia L, Peng YC, Tumas KC, Singh BK, Qi CF, Myers TG, Long CA, Liu C, Wang R, Rice CM, Su XZ. PMID: 32709745; PMCID: PMC7431001.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    7. The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation. Proc Natl Acad Sci U S A. 2020 07 14; 117(28):16567-16578. Wu J, Xia L, Yao X, Yu X, Tumas KC, Sun W, Cheng Y, He X, Peng YC, Singh BK, Zhang C, Qi CF, Bolland S, Best SM, Gowda C, Huang R, Myers TG, Long CA, Wang RF, Su XZ. PMID: 32606244; PMCID: PMC7368286.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    8. Evaluation of Single-Cell Cytokine Secretion and Cell-Cell Interactions with a Hierarchical Loading Microwell Chip. Cell Rep. 2020 04 28; 31(4):107574. Zhou Y, Shao N, Bessa de Castro R, Zhang P, Ma Y, Liu X, Huang F, Wang RF, Qin L. PMID: 32348757; PMCID: PMC7583657.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    9. Cell-Penetrating Nanoparticles Activate the Inflammasome to Enhance Antibody Production by Targeting Microtubule-Associated Protein 1-Light Chain 3 for Degradation. ACS Nano. 2020 03 24; 14(3):3703-3717. Zhu M, Du L, Zhao R, Wang HY, Zhao Y, Nie G, Wang RF. PMID: 32057231; PMCID: PMC7457719.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    10. Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development. J Clin Invest. 2019 12 02; 129(12):5261-5277. Tan P, He L, Xing C, Mao J, Yu X, Zhu M, Diao L, Han L, Zhou Y, You MJ, Wang HY, Wang RF. PMID: 31503548; PMCID: PMC6877338.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    11. JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4. J Clin Invest. 2019 08 08; 129(11):4745-4757. Fu C, Li Q, Zou J, Xing C, Luo M, Yin B, Chu J, Yu J, Liu X, Wang HY, Wang RF. PMID: 31393857; PMCID: PMC6819100.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    12. Investigation of parameters that determine Nano-DC vaccine transport. Biomed Microdevices. 2019 04 04; 21(2):39. Zhang J, Mai J, Li F, Shen J, Zhang G, Li J, Hinkle LE, Lin D, Liu X, Li Z, Wang RF, Mittendorf EA, Ferrari M, Shen H. PMID: 30949852; PMCID: PMC6686196.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    13. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019 Mar 01; 16(1):53. Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF. PMID: 30823925; PMCID: PMC6397457.
      View in: PubMed   Mentions: 223     Fields:    Translation:HumansAnimals
    14. Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma. Front Immunol. 2018; 9:2924. Ma Q, Long W, Xing C, Chu J, Luo M, Wang HY, Liu Q, Wang RF. PMID: 30619286; PMCID: PMC6308128.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    15. Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity. Nat Commun. 2018 11 23; 9(1):4964. Yu X, Du Y, Cai C, Cai B, Zhu M, Xing C, Tan P, Lin M, Wu J, Li J, Wang M, Wang HY, Su XZ, Wang RF. PMID: 30470758; PMCID: PMC6251914.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    16. Detection of host pathways universally inhibited after Plasmodium yoelii infection for immune intervention. Sci Rep. 2018 10 16; 8(1):15280. Xia L, Wu J, Pattaradilokrat S, Tumas K, He X, Peng YC, Huang R, Myers TG, Long CA, Wang R, Su XZ. PMID: 30327482; PMCID: PMC6191451.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    17. Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report. Oncol Lett. 2018 Dec; 16(6):6998-7007. Xia Y, Tian X, Wang J, Qiao D, Liu X, Xiao L, Liang W, Ban D, Chu J, Yu J, Wang R, Tian G, Wang M. PMID: 30546433; PMCID: PMC6256329.
      View in: PubMed   Mentions: 25  
    18. Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer. J Mol Cell Biol. 2018 08 01; 10(4):316-330. Zhao W, Zhu Q, Tan P, Ajibade A, Long T, Long W, Li Q, Liu P, Ning B, Wang HY, Wang RF. PMID: 29228234; PMCID: PMC6161409.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    19. PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4. J Mol Cell Biol. 2018 04 01; 10(2):147-160. Long W, Zhao W, Ning B, Huang J, Chu J, Li L, Ma Q, Xing C, Wang HY, Liu Q, Wang RF. PMID: 29452418; PMCID: PMC5951121.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    20. DHX29 functions as an RNA co-sensor for MDA5-mediated EMCV-specific antiviral immunity. PLoS Pathog. 2018 02; 14(2):e1006886. Zhu Q, Tan P, Li Y, Lin M, Li C, Mao J, Cui J, Zhao W, Wang HY, Wang RF. PMID: 29462185; PMCID: PMC5834211.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    21. BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1. Nat Commun. 2018 02 05; 9(1):500. Zhu S, Zhao D, Yan L, Jiang W, Kim JS, Gu B, Liu Q, Wang R, Xia B, Zhao JC, Song G, Mi W, Wang RF, Shi X, Lam HM, Dong X, Yu J, Chen K, Cao Q. PMID: 29402932; PMCID: PMC5799368.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    22. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma. J Control Release. 2018 02 28; 272:72-82. Zhu M, Ding X, Zhao R, Liu X, Shen H, Cai C, Ferrari M, Wang HY, Wang RF. PMID: 29325699; PMCID: PMC5825289.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    23. LRRC25 inhibits type I IFN signaling by targeting ISG15-associated RIG-I for autophagic degradation. EMBO J. 2018 02 01; 37(3):351-366. Du Y, Duan T, Feng Y, Liu Q, Lin M, Cui J, Wang RF. PMID: 29288164; PMCID: PMC5793803.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsCells
    24. NLRP11 attenuates Toll-like receptor signalling by targeting TRAF6 for degradation via the ubiquitin ligase RNF19A. Nat Commun. 2017 12 07; 8(1):1977. Wu C, Su Z, Lin M, Ou J, Zhao W, Cui J, Wang RF. PMID: 29215004; PMCID: PMC5719394.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    25. Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. Mol Cell. 2017 Oct 19; 68(2):293-307.e5. Tan P, He L, Cui J, Qian C, Cao X, Lin M, Zhu Q, Li Y, Xing C, Yu X, Wang HY, Wang RF. PMID: 29053956.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    26. LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation. Sci Rep. 2017 10 18; 7(1):13448. Feng Y, Duan T, Du Y, Jin S, Wang M, Cui J, Wang RF. PMID: 29044191; PMCID: PMC5647368.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    27. Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction. Oncol Lett. 2017 Nov; 14(5):6001-6011. Zhang C, Wang YQ, Jin G, Wu S, Cui J, Wang RF. PMID: 29113238; PMCID: PMC5661485.
      View in: PubMed   Mentions: 12  
    28. USP26 functions as a negative regulator of cellular reprogramming by stabilising PRC1 complex components. Nat Commun. 2017 08 24; 8(1):349. Ning B, Zhao W, Qian C, Liu P, Li Q, Li W, Wang RF. PMID: 28839133; PMCID: PMC5571198.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    29. The distribution and function of human memory T cell subsets in lung cancer. Immunol Res. 2017 06; 65(3):639-650. Sheng SY, Gu Y, Lu CG, Zou JY, Hong H, Wang R. PMID: 28101811; PMCID: PMC5440487.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    30. TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination. Cell Death Dis. 2017 05 25; 8(5):e2831. Zhang J, Zhang C, Cui J, Ou J, Han J, Qin Y, Zhi F, Wang RF. PMID: 28542145; PMCID: PMC5520693.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    31. Histone demethylases UTX and JMJD3 are required for NKT cell development in mice. Cell Biosci. 2017; 7:25. Northrup D, Yagi R, Cui K, Proctor WR, Wang C, Placek K, Pohl LR, Wang R, Ge K, Zhu J, Zhao K. PMID: 28529687; PMCID: PMC5436453.
      View in: PubMed   Mentions: 15  
    32. FOSL1 Inhibits Type I Interferon Responses to Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions. mBio. 2017 01 03; 8(1). Cai B, Wu J, Yu X, Su XZ, Wang RF. PMID: 28049150; PMCID: PMC5210502.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    33. A special issue on cancer immunotherapy. Cell Res. 2017 01; 27(1):1-2. Wang RF. PMID: 28057935; PMCID: PMC5223239.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    34. The Characteristics of Naive-like T Cells in Tumor-infiltrating Lymphocytes From Human Lung Cancer. J Immunother. 2017 01; 40(1):1-10. Sheng SY, Gu Y, Lu CG, Tang YY, Zou JY, Zhang YQ, Wang RF, Hong H. PMID: 27828929.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    35. Immune targets and neoantigens for cancer immunotherapy and precision medicine. Cell Res. 2017 Jan; 27(1):11-37. Wang RF, Wang HY. PMID: 28025978; PMCID: PMC5223235.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    36. Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality. Immunity. 2016 11 15; 45(5):1093-1107. Yu X, Cai B, Wang M, Tan P, Ding X, Wu J, Li J, Li Q, Liu P, Xing C, Wang HY, Su XZ, Wang RF. PMID: 27793594; PMCID: PMC7128466.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    37. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer. Oncogene. 2017 04; 36(15):2095-2104. Zhang H, Ye YL, Li MX, Ye SB, Huang WR, Cai TT, He J, Peng JY, Duan TH, Cui J, Zhang XS, Zhou FJ, Wang RF, Li J. PMID: 27721403.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    38. Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model. PLoS Pathog. 2016 Oct; 12(10):e1005930. Yao X, Wu J, Lin M, Sun W, He X, Gowda C, Bolland S, Long CA, Wang R, Su XZ. PMID: 27716849; PMCID: PMC5055354.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    39. USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 Signalosome. Mol Cell. 2016 10 20; 64(2):267-281. Lin M, Zhao Z, Yang Z, Meng Q, Tan P, Xie W, Qin Y, Wang RF, Cui J. PMID: 27692986.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    40. TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses. Mol Cell. 2016 10 06; 64(1):105-119. Chen M, Meng Q, Qin Y, Liang P, Tan P, He L, Zhou Y, Chen Y, Huang J, Wang RF, Cui J. PMID: 27666593.
      View in: PubMed   Mentions: 178     Fields:    Translation:HumansAnimalsCells
    41. TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy. Cell Rep. 2016 08 16; 16(7):1988-2002. Liu T, Tang Q, Liu K, Xie W, Liu X, Wang H, Wang RF, Cui J. PMID: 27498865.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    42. The BECN1-USP19 axis plays a role in the crosstalk between autophagy and antiviral immune responses. Autophagy. 2016 07 02; 12(7):1210-1. Cui J, Jin S, Wang RF. PMID: 27096686; PMCID: PMC4990993.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    43. USP19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin-1. EMBO J. 2016 Apr 15; 35(8):866-80. Jin S, Tian S, Chen Y, Zhang C, Xie W, Xia X, Cui J, Wang RF. PMID: 26988033; PMCID: PMC4972138.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    44. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1. Cell Res. 2016 05; 26(5):613-28. Qin Y, Liu Q, Tian S, Xie W, Cui J, Wang RF. PMID: 26915459; PMCID: PMC4856760.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    45. Reversible ubiquitination shapes NLRC5 function and modulates NF-κB activation switch. J Cell Biol. 2015 Dec 07; 211(5):1025-40. Meng Q, Cai C, Sun T, Wang Q, Xie W, Wang R, Cui J. PMID: 26620909; PMCID: PMC4674279.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    46. Targeting epigenetic regulations in cancer. Acta Biochim Biophys Sin (Shanghai). 2016 Jan; 48(1):97-109. Ning B, Li W, Zhao W, Wang R. PMID: 26508480; PMCID: PMC4689160.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    47. USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms. Sci Rep. 2015 Aug 04; 5:12738. Yang Z, Xian H, Hu J, Tian S, Qin Y, Wang RF, Cui J. PMID: 26240016; PMCID: PMC4523862.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    48. JMJD3 as an epigenetic regulator in development and disease. Int J Biochem Cell Biol. 2015 Oct; 67:148-57. Burchfield JS, Li Q, Wang HY, Wang RF. PMID: 26193001; PMCID: PMC4564304.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    49. Genome-wide Analysis of Host-Plasmodium yoelii Interactions Reveals Regulators of the Type I Interferon Response. Cell Rep. 2015 Jul 28; 12(4):661-72. Wu J, Cai B, Sun W, Huang R, Liu X, Lin M, Pattaradilokrat S, Martin S, Qi Y, Nair SC, Bolland S, Cohen JI, Austin CP, Long CA, Myers TG, Wang RF, Su XZ. PMID: 26190101; PMCID: PMC4520759.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    50. Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells. PLoS One. 2015; 10(5):e0124094. Kiniwa Y, Li J, Wang M, Sun C, Lee JE, Wang RF, Wang HY. PMID: 25993655; PMCID: PMC4439028.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    51. Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response. Cell Rep. 2015 May 12; 11(6):957-966. Xia X, Mai J, Xu R, Perez JET, Guevara ML, Shen Q, Mu C, Tung HY, Corry DB, Evans SE, Liu X, Ferrari M, Zhang Z, Li XC, Wang RF, Shen H. PMID: 25937283; PMCID: PMC4431902.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    52. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat Commun. 2014 Dec 22; 5:5780. Li Q, Zou J, Wang M, Ding X, Chepelev I, Zhou X, Zhao W, Wei G, Cui J, Zhao K, Wang HY, Wang RF. PMID: 25531312; PMCID: PMC4274750.
      View in: PubMed   Mentions: 80     Fields:    Translation:AnimalsCells
    53. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma. BMC Cancer. 2014 Nov 18; 14:836. Wu S, Chen J, Dong P, Zhang S, He Y, Sun L, Zhu J, Cheng Y, Li X, Tang A, Huang Y, Gui Y, Liu C, Yang G, Zhou F, Cai Z, Wang R. PMID: 25408144; PMCID: PMC4242595.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    54. Applications of nanomaterials as vaccine adjuvants. Hum Vaccin Immunother. 2014; 10(9):2761-74. Zhu M, Wang R, Nie G. PMID: 25483497; PMCID: PMC4977448.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimals
    55. An epigenetic switch induced by Shh signalling regulates gene activation during development and medulloblastoma growth. Nat Commun. 2014 Nov 05; 5:5425. Shi X, Zhang Z, Zhan X, Cao M, Satoh T, Akira S, Shpargel K, Magnuson T, Li Q, Wang R, Wang C, Ge K, Wu J. PMID: 25370275; PMCID: PMC5232137.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    56. Stage-dependent and locus-specific role of histone demethylase Jumonji D3 (JMJD3) in the embryonic stages of lung development. PLoS Genet. 2014 Jul; 10(7):e1004524. Li Q, Wang HY, Chepelev I, Zhu Q, Wei G, Zhao K, Wang RF. PMID: 25079229; PMCID: PMC4117460.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    57. The future potential for cocaine vaccines. Expert Opin Biol Ther. 2014 Sep; 14(9):1271-83. Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR. PMID: 24835496; PMCID: PMC4154474.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    58. Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality. Proc Natl Acad Sci U S A. 2014 Jan 28; 111(4):E511-20. Wu J, Tian L, Yu X, Pattaradilokrat S, Li J, Wang M, Yu W, Qi Y, Zeituni AE, Nair SC, Crampton SP, Orandle MS, Bolland SM, Qi CF, Long CA, Myers TG, Coligan JE, Wang R, Su XZ. PMID: 24474800; PMCID: PMC3910569.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    59. Current advances in T-cell-based cancer immunotherapy. Immunotherapy. 2014; 6(12):1265-78. Wang M, Yin B, Wang HY, Wang RF. PMID: 25524383; PMCID: PMC4372895.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    60. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother. 2014; 10(11):3270-85. Cui J, Chen Y, Wang HY, Wang RF. PMID: 25625930; PMCID: PMC4514086.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCells
    61. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 2014 Apr; 24(4):400-16. Cui J, Song Y, Li Y, Zhu Q, Tan P, Qin Y, Wang HY, Wang RF. PMID: 24366338; PMCID: PMC3975496.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    62. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 2013 Jul; 34(7):307-16. Ajibade AA, Wang HY, Wang RF. PMID: 23664135.
      View in: PubMed   Mentions: 162     Fields:    Translation:HumansAnimalsCells
    63. Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinoma. PLoS One. 2013; 8(4):e59936. Wu S, Lv Z, Wang Y, Sun L, Jiang Z, Xu C, Zhao J, Sun X, Li X, Hu L, Tang A, Gui Y, Zhou F, Cai Z, Wang R. PMID: 23634203; PMCID: PMC3636239.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    64. HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs. 2014 Apr; 32(2):235-242. Sonpavde G, Wang M, Peterson LE, Wang HY, Joe T, Mims MP, Kadmon D, Ittmann MM, Wheeler TM, Gee AP, Wang RF, Hayes TG. PMID: 23609828; PMCID: PMC4100683.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    65. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production. Exp Parasitol. 2013 Jul; 134(3):389-99. Brumlik MJ, Pandeswara S, Ludwig SM, Jeansonne DP, Lacey MR, Murthy K, Daniel BJ, Wang RF, Thibodeaux SR, Church KM, Hurez V, Kious MJ, Zhang B, Alagbala A, Xia X, Curiel TJ. PMID: 23541881; PMCID: PMC4226171.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    66. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 2013 Mar 05; 17(3):411-22. Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ, Ren Y, Yin Z, Hamilton DJ, Reardon PR, Sherman V, Wang HY, Phillips KJ, Webb P, Wong ST, Wang RF, Hsueh WA. PMID: 23473035; PMCID: PMC3619392.
      View in: PubMed   Mentions: 210     Fields:    Translation:HumansAnimalsCells
    67. Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell. 2013 Feb 28; 152(5):1037-50. Zhao W, Li Q, Ayers S, Gu Y, Shi Z, Zhu Q, Chen Y, Wang HY, Wang RF. PMID: 23452852; PMCID: PMC3742052.
      View in: PubMed   Mentions: 90     Fields:    Translation:AnimalsCells
    68. Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy. PLoS One. 2013; 8(2):e56730. Wang M, Yin B, Matsueda S, Deng L, Li Y, Zhao W, Zou J, Li Q, Loo C, Wang RF, Wang HY. PMID: 23437226; PMCID: PMC3578933.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    69. Evidence for GAL3ST4 mutation as the potential cause of pectus excavatum. Cell Res. 2012 Dec; 22(12):1712-5. Wu S, Sun X, Zhu W, Huang Y, Mou L, Liu M, Li X, Li F, Li X, Zhang Y, Wang Z, Li W, Li Z, Tang A, Gui Y, Wang R, Li W, Cai Z, Wang D. PMID: 23147795; PMCID: PMC3515755.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    70. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy. PLoS One. 2012; 7(9):e45756. Matsueda S, Wang M, Weng J, Li Y, Yin B, Zou J, Li Q, Zhao W, Peng W, Legras X, Loo C, Wang RF, Wang HY. PMID: 23029225; PMCID: PMC3447865.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    71. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice. Cell Res. 2012 May; 22(5):822-35. Tong Y, Cui J, Li Q, Zou J, Wang HY, Wang RF. PMID: 22473004; PMCID: PMC3343662.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    72. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol. 2012 Mar 04; 13(4):387-95. Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang HY, Wang RF. PMID: 22388039; PMCID: PMC3760161.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    73. Molecular cloning of large alternative transcripts based on comparative phylogenetic analysis and exploration of an EST database. Anal Biochem. 2012 May 15; 424(2):140-1. Ji J, Wang R. PMID: 22387390; PMCID: PMC3327802.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    74. TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Immunity. 2012 Jan 27; 36(1):43-54. Ajibade AA, Wang Q, Cui J, Zou J, Xia X, Wang M, Tong Y, Hui W, Liu D, Su B, Wang HY, Wang RF. PMID: 22226633; PMCID: PMC3750978.
      View in: PubMed   Mentions: 96     Fields:    Translation:AnimalsCells
    75. Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling. Adv Immunol. 2012; 114:151-76. Wang HY, Wang RF. PMID: 22449781; PMCID: PMC3760162.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    76. Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells. J Zhejiang Univ Sci B. 2012 Jan; 13(1):11-9. Shi Z, Bai R, Fu ZX, Zhu YL, Wang RF, Zheng S. PMID: 22205615; PMCID: PMC3251747.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    77. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity. 2011 Jun 24; 34(6):843-53. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ, Wang RF. PMID: 21703539; PMCID: PMC3150212.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansAnimalsCells
    78. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell. 2010 Apr 30; 141(3):483-96. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, Wang RF. PMID: 20434986; PMCID: PMC3150216.
      View in: PubMed   Mentions: 212     Fields:    Translation:HumansAnimalsCells
    79. Molecular cloning and characterization of MHC class I- and II-restricted tumor antigens recognized by T cells. Curr Protoc Immunol. 2009 Feb; Chapter 20:Unit 20.10. Wang RF. PMID: 19235768.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    80. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A. 2008 Oct 07; 105(40):15505-10. Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF. PMID: 18832156; PMCID: PMC2563129.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCells
    81. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. Hum Immunol. 2008 Nov; 69(11):811-4. Wang RF. PMID: 18817828.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    82. Tumor-associated galectin-3 modulates the function of tumor-reactive T cells. Cancer Res. 2008 Sep 01; 68(17):7228-36. Peng W, Wang HY, Miyahara Y, Peng G, Wang RF. PMID: 18757439; PMCID: PMC3181121.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    83. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene. 2008 Jan 07; 27(2):181-9. Wang RF, Miyahara Y, Wang HY. PMID: 18176599.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    84. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res. 2007 Dec 01; 13(23):6947-58. Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF. PMID: 18056169.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCells
    85. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 2007 Aug; 27(2):334-48. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. PMID: 17656116.
      View in: PubMed   Mentions: 212     Fields:    Translation:HumansCells
    86. Regulatory T cells and cancer. Curr Opin Immunol. 2007 Apr; 19(2):217-23. Wang HY, Wang RF. PMID: 17306521.
      View in: PubMed   Mentions: 130     Fields:    Translation:AnimalsCells
    87. Regulatory T cells and innate immune regulation in tumor immunity. Springer Semin Immunopathol. 2006 Aug; 28(1):17-23. Wang RF. PMID: 16838179.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    88. CD4+ T-cell response to mitochondrial cytochrome B in human melanoma. Cancer Res. 2006 Jun 01; 66(11):5919-26. Voo KS, Zeng G, Mu JB, Zhou J, Su XZ, Wang RF. PMID: 16740732.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    89. Regulatory T cells and toll-like receptors in cancer therapy. Cancer Res. 2006 May 15; 66(10):4987-90. Wang RF. PMID: 16707417.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    90. Regulatory T cells and Toll-like receptors in tumor immunity. Semin Immunol. 2006 Apr; 18(2):136-42. Wang RF, Peng G, Wang HY. PMID: 16469504.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    91. Functional control of regulatory T cells and cancer immunotherapy. Semin Cancer Biol. 2006 Apr; 16(2):106-14. Wang RF. PMID: 16423537.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    92. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer. Semin Cancer Biol. 2006 Feb; 16(1):73-9. Wang RF. PMID: 16140545.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    93. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science. 2005 Aug 26; 309(5739):1380-4. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF. PMID: 16123302.
      View in: PubMed   Mentions: 278     Fields:    Translation:HumansAnimalsCells
    94. Antigen-specific CD4+ regulatory T cells in cancer: implications for immunotherapy. Microbes Infect. 2005 Jun; 7(7-8):1056-62. Wang HY, Wang RF. PMID: 15914063.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    95. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J Immunol. 2005 Mar 01; 174(5):2661-70. Wang HY, Peng G, Guo Z, Shevach EM, Wang RF. PMID: 15728473.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    96. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res. 2005 Feb 15; 65(4):1577-86. Voo KS, Peng G, Guo Z, Fu T, Li Y, Frappier L, Wang RF. PMID: 15735048.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    97. Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo. J Clin Invest. 2004 Aug; 114(4):542-50. Fu T, Voo KS, Wang RF. PMID: 15314691; PMCID: PMC503775.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCellsPHPublic Health
    98. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med. 2004 Feb 16; 199(4):459-70. Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, Rooney CM, Wang RF. PMID: 14769850; PMCID: PMC2211826.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    99. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity. 2004 Jan; 20(1):107-18. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF. PMID: 14738769.
      View in: PubMed   Mentions: 164     Fields:    Translation:HumansCells
    100. Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells. Methods. 2003 Mar; 29(3):227-35. Wang RF. PMID: 12725788.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    101. Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. Cancer Res. 2002 Dec 15; 62(24):7195-9. Voo KS, Fu T, Heslop HE, Brenner MK, Rooney CM, Wang RF. PMID: 12499257.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    102. Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme. Cancer Res. 2002 Oct 01; 62(19):5505-9. Topalian SL, Gonzales MI, Ward Y, Wang X, Wang RF. PMID: 12359760.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    103. Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens. Immunol Rev. 2002 Oct; 188:65-80. Wang RF. PMID: 12445282.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    104. T cell-mediated immune responses in melanoma: implications for immunotherapy. Crit Rev Oncol Hematol. 2002 Jul; 43(1):1-11. Wang RF, Zeng G, Johnston SF, Voo K, Ying H. PMID: 12098604.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    105. Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion. Clin Immunol. 2002 Jul; 104(1):14-20. Hayashi T, Tanaka H, Tanaka J, Wang R, Averbook BJ, Cohen PA, Shu S. PMID: 12139943.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    106. Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. Cancer Res. 2002 Jul 01; 62(13):3630-5. Zeng G, Li Y, El-Gamil M, Sidney J, Sette A, Wang RF, Rosenberg SA, Robbins PF. PMID: 12097265; PMCID: PMC2562286.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    107. Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis. J Exp Med. 2002 Jun 03; 195(11):1397-406. Wang HY, Zhou J, Zhu K, Riker AI, Marincola FM, Wang RF. PMID: 12045238; PMCID: PMC2193545.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    108. Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J Clin Invest. 2002 Jun; 109(11):1463-70. Wang HY, Fu T, Wang G, Zeng G, Perry-Lalley DM, Yang JC, Restifo NP, Hwu P, Wang RF. PMID: 12045260; PMCID: PMC151000.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    109. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat Biotechnol. 2002 Feb; 20(2):149-54. Wang RF, Wang HY. PMID: 11821860.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    110. Immunization against endogenous retroviral tumor-associated antigens. Cancer Res. 2001 Nov 01; 61(21):7920-4. Kershaw MH, Hsu C, Mondesire W, Parker LL, Wang G, Overwijk WW, Lapointe R, Yang JC, Wang RF, Restifo NP, Hwu P. PMID: 11691813; PMCID: PMC2247477.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    111. MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumors. Trends in Immunology. 2001; 22(8):423. Rong-Fu Wang. . View Publication.
    112. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol. 2001 May; 22(5):269-76. Wang RF. PMID: 11323286.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    113. CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production. Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):3964-9. Zeng G, Wang X, Robbins PF, Rosenberg SA, Wang RF. PMID: 11259659; PMCID: PMC31162.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    114. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. J Immunol. 2000 Jul 15; 165(2):1153-9. Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF. PMID: 10878395; PMCID: PMC2241745.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    115. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J Immunother. 2000 Jan; 23(1):17-27. Kawakami Y, Dang N, Wang X, Tupesis J, Robbins PF, Wang RF, Wunderlich JR, Yannelli JR, Rosenberg SA. PMID: 10687134.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    116. Human tumor antigens: implications for cancer vaccine development. J Mol Med (Berl). 1999 Sep; 77(9):640-55. Wang RF. PMID: 10569202.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    117. Human tumor antigens for cancer vaccine development. Immunol Rev. 1999 Aug; 170:85-100. Wang RF, Rosenberg SA. PMID: 10566144.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    118. Cancer therapy using a self-replicating RNA vaccine. Nat Med. 1999 Jul; 5(7):823-7. Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP. PMID: 10395329; PMCID: PMC1976249.
      View in: PubMed   Mentions: 84     Fields:    Translation:AnimalsCells
    119. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science. 1999 May 21; 284(5418):1351-4. Wang RF, Wang X, Atwood AC, Topalian SL, Rosenberg SA. PMID: 10334988.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    120. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells. J Exp Med. 1999 May 17; 189(10):1659-68. Wang RF, Wang X, Rosenberg SA. PMID: 10330445; PMCID: PMC2193637.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    121. NY-ESO-1 may be a potential target for lung cancer immunotherapy. Cancer J Sci Am. 1999 Jan-Feb; 5(1):20-5. Lee L, Wang RF, Wang X, Mixon A, Johnson BE, Rosenberg SA, Schrump DS. PMID: 10188057.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    122. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J Immunol. 1998 Oct 01; 161(7):3598-606. Wang RF, Johnston SL, Zeng G, Topalian SL, Schwartzentruber DJ, Rosenberg SA. PMID: 9759882.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    123. Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens. Cancer Res. 1998 Aug 15; 58(16):3519-25. Wang RF, Wang X, Johnston SL, Zeng G, Robbins PF, Rosenberg SA. PMID: 9721852.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    124. The use of melanosomal proteins in the immunotherapy of melanoma. J Immunother. 1998 Jul; 21(4):237-46. Kawakami Y, Robbins PF, Wang RF, Parkhurst M, Kang X, Rosenberg SA. PMID: 9672845.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    125. Escherichia coli mrsC is an allele of hflB, encoding a membrane-associated ATPase and protease that is required for mRNA decay. J Bacteriol. 1998 Apr; 180(7):1929-38. Wang RF, O'Hara EB, Aldea M, Bargmann CI, Gromley H, Kushner SR. PMID: 9537394; PMCID: PMC107109.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    126. The Escherichia coli mrsC gene is required for cell growth and mRNA decay. J Bacteriol. 1998 Apr; 180(7):1920-8. Granger LL, O'Hara EB, Wang RF, Meffen FV, Armstrong K, Yancey SD, Babitzke P, Kushner SR. PMID: 9537393; PMCID: PMC107108.
      View in: PubMed   Mentions: 9     Fields:    Translation:Cells
    127. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J Immunol. 1998 Jan 15; 160(2):890-7. Wang RF, Johnston SL, Southwood S, Sette A, Rosenberg SA. PMID: 9551926.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    128. Tumor antigens discovery: perspectives for cancer therapy. Mol Med. 1997 Nov; 3(11):716-31. Wang RF. PMID: 9407548; PMCID: PMC2230241.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    129. Induction of melanoma reactive T cells by stimulator cells expressing melanoma epitope-major histocompatibility complex class I fusion proteins. Cancer Res. 1997 Jan 15; 57(2):202-5. Kang X, Robbins PF, Fitzgerald EB, Wang R, Rosenberg SA, Kawakami Y. PMID: 9000554.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    130. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med. 1996 Dec 01; 184(6):2207-16. Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA. PMID: 8976176; PMCID: PMC2211562.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    131. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J Leukoc Biol. 1996 Sep; 60(3):296-309. Wang RF, Rosenberg SA. PMID: 8830785.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    132. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med. 1996 Mar 01; 183(3):1131-40. Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA. PMID: 8642255; PMCID: PMC2192321.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimalsCells
    133. Identification of tumor-regression antigens in melanoma. Important Adv Oncol. 1996; 3-21. Kawakami Y, Robbins PF, Wang RF, Rosenberg SA. PMID: 8791125.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    134. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res. 1996; 70:145-77. Rosenberg SA, Kawakami Y, Robbins PF, Wang R. PMID: 8902056.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    135. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol. 1995 Aug 01; 155(3):1343-8. Kang X, Kawakami Y, el-Gamil M, Wang R, Sakaguchi K, Yannelli JR, Appella E, Rosenberg SA, Robbins PF. PMID: 7543520.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    136. Mammalian cell/vaccinia virus expression vectors with increased stability of retroviral sequences in Escherichia coli: production of feline immunodeficiency virus envelope protein. Gene. 1995 Feb 14; 153(2):197-202. Wang RF, Mullins JI. PMID: 7875588.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    137. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med. 1995 Feb 01; 181(2):799-804. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA. PMID: 7836932; PMCID: PMC2191858.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    138. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene. 1991 Apr; 100:195-9. Wang RF, Kushner SR. PMID: 2055470.
      View in: PubMed   Mentions: 652     Fields:    Translation:Cells
    Rongfu's Networks
    Concepts (581)
    Derived automatically from this person's publications.
    Co-Authors (1)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department